Generics News
-
US company leverages on generics
Generics | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: US based Par Pharmaceutical has entered into agreements with Watson Pharmaceuticals and Actavis Group to purc...Read more
-
NATCO wins compulsory license for anti-cancer drug
Generics | News | By BioSpectrum Bureau | 0 Comment | 16 Mar, 2012
In a landmark decision, Hyderabad-based NATCO Pharma has been granted compulsory license for Sorafenib Tosylate sold und...Read more
-
Mylan gets FDA nod for Thiamine Hydrochloride Injection
Generics | News | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2012
Singapore: Mylan Institutional business has received final approval from the US Food and Drug Administration (FDA) for ...Read more
-
Big pharma to drive R&D innovation with $4.4 bn
Generics | News | By BioSpectrum Bureau | 0 Comment | 11 Jul, 2013
Singapore: The European Commission (EC) and other leading pharma giants have come together to invest $4.4 billion into p...Read more
-
Multiple organzations join hands to curb fake drug business
Generics | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: US Pharmacopeial Convention (USP) is gearing up its efforts to combat fake medicine circulating in the market...Read more
-
Arvind sets up $42.37 mn plant top tap US market
Generics | News | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2013
Singapore: Indian pharmaceutical firm, Arvind Remedies has been gearing up to take the US market by storm. The company h...Read more
-
Lilly strengthens its foothold in China
Generics | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore, June 15, 2012: In support of its commitment to maximize growth opportunities in China, Eli Lilly has plans ...Read more
-
Cipla gets drug pricing breather from Delhi Court
Generics | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013
Singapore: India's Delhi High Court has extended the operation of its earlier order asking the central government not t...Read more
-
Industry body expresses concern over Nexavar decision
Generics | News | By BioSpectrum Bureau | 0 Comment | 16 Mar, 2012
The Association of Biotechnology Led Enterprises (ABLE), a national forum that represents the $4 billion biotechnology i...Read more
-
US FDA approves Suprax 400 mg by Lupin
Generics | Regulatory | By BioSpectrum Bureau | 0 Comment | 06 Jun, 2012
Mumbai: Lupin Pharmaceuticals, a subsidiary of India-based Lupin, has received approval for Suprax (Cefixime) Capsules 4...Read more
-
Tiyanyin pharma all set for GMP inspection
Generics | Regulatory | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2014
Singapore: China-based Tianyin Pharmaceutical is looking ahead to get its Qionglai Facility (QLF) GMP certified post ins...Read more
-
Simcere, Zhuhai enter share transfer agreement
Generics | News | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2013
Singapore: Leading pharmaceutical company, Simcere Pharmaceutical, announced sale of equity interest in Jilin Bodapharma...Read more
-
New CoolPal Vertos Advance launched by Pelican BioThermal
Generics | News | 0 Comment | 19 Jan, 2017
US based Pelical BioThermal which is a global leader providing the broadcast and most innovative range of temperature-co...Read more
-
CEPI board meeting with a focus on identifying disease priorities and future strategy
Generics | News | 0 Comment | 19 Dec, 2016
The Department of Biotechnology (DBT) will be partnering in the Coalition for Epidemic Preparedness and Innovations (CEP...Read more
